JP2024511425A5 - - Google Patents
Info
- Publication number
- JP2024511425A5 JP2024511425A5 JP2023558179A JP2023558179A JP2024511425A5 JP 2024511425 A5 JP2024511425 A5 JP 2024511425A5 JP 2023558179 A JP2023558179 A JP 2023558179A JP 2023558179 A JP2023558179 A JP 2023558179A JP 2024511425 A5 JP2024511425 A5 JP 2024511425A5
- Authority
- JP
- Japan
- Prior art keywords
- immune cell
- cancer
- dna
- sample
- methylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166200P | 2021-03-25 | 2021-03-25 | |
| US63/166,200 | 2021-03-25 | ||
| PCT/US2022/071365 WO2022204730A1 (en) | 2021-03-25 | 2022-03-25 | Methods and compositions for quantifying immune cell dna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511425A JP2024511425A (ja) | 2024-03-13 |
| JP2024511425A5 true JP2024511425A5 (https=) | 2025-04-01 |
Family
ID=81346077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558179A Pending JP2024511425A (ja) | 2021-03-25 | 2022-03-25 | 免疫細胞ｄｎａを定量するための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240344115A1 (https=) |
| EP (1) | EP4314329A1 (https=) |
| JP (1) | JP2024511425A (https=) |
| WO (1) | WO2022204730A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025038399A1 (en) * | 2023-08-11 | 2025-02-20 | Guardant Health, Inc. | Methylated enrichment methods for single-molecule genetic and epigenetic sequencing |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US20030017081A1 (en) | 1994-02-10 | 2003-01-23 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| WO2003046146A2 (en) | 2001-11-28 | 2003-06-05 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| ATE443765T1 (de) | 2003-03-21 | 2009-10-15 | Santaris Pharma As | Analoga kurzer interferierender rna (sirna) |
| US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
| GB2559073A (en) | 2012-06-08 | 2018-07-25 | Pacific Biosciences California Inc | Modified base detection with nanopore sequencing |
| CN104781421B (zh) | 2012-09-04 | 2020-06-05 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| EP4358097A1 (en) | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
| US11384382B2 (en) * | 2016-04-14 | 2022-07-12 | Guardant Health, Inc. | Methods of attaching adapters to sample nucleic acids |
| CN110168099B (zh) * | 2016-06-07 | 2024-06-07 | 加利福尼亚大学董事会 | 用于疾病和病症分析的无细胞dna甲基化模式 |
| WO2018009723A1 (en) | 2016-07-06 | 2018-01-11 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| MX2019007444A (es) | 2016-12-22 | 2019-08-16 | Guardant Health Inc | Metodos y sistemas para analisis de moleculas de acido nucleico. |
| WO2020160414A1 (en) | 2019-01-31 | 2020-08-06 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| EP4222278A1 (en) * | 2020-09-30 | 2023-08-09 | Guardant Health, Inc. | Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease |
| EP4594522A2 (en) * | 2022-09-27 | 2025-08-06 | Guardant Health, Inc. | Methods for quantifying immune cell dna |
-
2022
- 2022-03-25 WO PCT/US2022/071365 patent/WO2022204730A1/en not_active Ceased
- 2022-03-25 JP JP2023558179A patent/JP2024511425A/ja active Pending
- 2022-03-25 EP EP22718032.0A patent/EP4314329A1/en active Pending
-
2023
- 2023-09-19 US US18/470,187 patent/US20240344115A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11560558B2 (en) | Methods of capturing cell-free methylated DNA and uses of same | |
| JP2023139162A (ja) | メチローム解析を用いる癌の検出及び分類 | |
| US10829821B2 (en) | Leukemia methylation markers and uses thereof | |
| CN113661249A (zh) | 用于分离无细胞dna的组合物和方法 | |
| KR20190095410A (ko) | 핵산 분자를 분석하기 위한 방법 및 시스템 | |
| US20240209453A1 (en) | Liver cancer methylation and protein markers and their uses | |
| CN111742062A (zh) | 用于诊断癌症的甲基化标志物 | |
| Li et al. | Single nucleotide polymorphism–based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression | |
| CN111755072B (zh) | 一种同时检测甲基化水平、基因组变异和插入片段的方法及装置 | |
| EP3976822A1 (en) | Methods and systems for improving patient monitoring after surgery | |
| EP4504971A1 (en) | Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules | |
| JP2023551292A5 (https=) | ||
| CN119923475A (zh) | 用于检测和减少样品制备诱导的甲基化人为假象的方法 | |
| WO2024233502A1 (en) | Cell-free dna blood-based test for cancer screening | |
| WO2024073508A2 (en) | Methods and compositions for quantifying immune cell dna | |
| JP2024511425A5 (https=) | ||
| JP2025522763A (ja) | 異常にメチル化されたｄｎａの富化 | |
| KR20240046525A (ko) | 세포-유리 dna에 대한 tet-보조 피리딘 보란 시퀀싱과 관련된 조성물 및 방법 | |
| JP7836823B2 (ja) | サンプルを臨床関連カテゴリーに分類する方法 | |
| JP7843243B2 (ja) | 分配された核酸を使用した配列決定のための方法 | |
| JP2024523401A5 (https=) | ||
| JP7836822B2 (ja) | サンプルを臨床関連カテゴリーに分類する方法 | |
| WO2022262831A1 (zh) | 用于评估肿瘤的物质及其方法 | |
| US20250201344A1 (en) | Methods and systems for identifying an origin of a variant | |
| US20250364077A1 (en) | Generalized probabilistic generative modeling method for analysis of tumor methylated molecules in target capture regions |